Furthermore, we identified that high expression of FOSL1, MCAM, NNMT, and LY6K, and low expression of LAMC3, MSN, and PRLR were correlated with poor prognosis of BC based on patients from the TCGA database (Figure 4). This evidence concerns the gene LY6K and breast cancer.